Search results

Evidence-based recommendations on focal therapy using high-intensity focused ultrasound for localised prostate cancer. This involves using high-intensity focused ultrasound to heat up and destroy only the areas of the prostate with cancer (focal therapy). The aim is to destroy the cancer while reducing damage to healthy prostate tissue.

Result type

HealthTech guidance

Published

5 April 2023

Evidence-based recommendations on percutaneous transluminal renal sympathetic denervation for resistant hypertension. This involves inserting a device through the skin (percutaneous) into an artery in the thigh and then into the renal arteries (transluminal). It sends radio or sound waves to destroy the nerves in the renal arteries (sympathetic denervation). The aim is to lower blood pressure.

Result type

HealthTech guidance

Published

1 March 2023

Evidence-based recommendations on endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an option. This involves inserting a stent through an endoscope into the gallbladder.

Result type

HealthTech guidance

Published

22 June 2023

Evidence-based recommendations on transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults. This involves electrically stimulating nerves in the throat or neck, while the person swallows. The aim is to strengthen the muscles involved in swallowing.

Result type

HealthTech guidance

Published

19 December 2018

Late-stage assessment (LSA) guidance on compression products for treating venous leg ulcers.

Result type

HealthTech guidance

Published

27 August 2025

Evidence-based recommendations on alectinib (Alecensa) for untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

8 August 2018

Late stage assessment (LSA) guidance on one-piece closed bags for colostomies

Result type

HealthTech guidance

Published

10 July 2025

Evidence-based recommendations on arsenic trioxide (Trisenox) for treating acute promyelocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

13 June 2018

Evidence-based recommendations on tofacitinib (Xeljanz) for treating active psoriatic arthritis in adults after inadequate response to DMARDs.

Result type

Technology appraisal guidance

Published

3 October 2018

Evidence-based recommendations on naltrexone (Nalorex) for managing opioid dependence in adults.

Result type

Technology appraisal guidance

Published

24 January 2007

Evidence-based recommendations on apremilast (Otezla) for treating active psoriatic arthritis.

Result type

Technology appraisal guidance

Published

22 February 2017

Evidence-based recommendations on vagus nerve stimulation for treatment-resistant depression in adults. This involves implanting an electrical stimulator under the skin of the chest and connecting it by wires to the vagus nerve.

Result type

HealthTech guidance

Published

12 August 2020

Evidence-based recommendations endobronchial nerve ablation for chronic obstructive pulmonary disease. This involves destroying (ablating) the nerves on the outside of the airway (endobronchial nerves) to improve breathing.

Result type

HealthTech guidance

Published

15 December 2021

Evidence-based recommendations on extracorporeal whole liver perfusion for acute liver failure. This involves blood being diverted to a whole liver (perfusion) outside the body and returned to the patient.

Result type

HealthTech guidance

Published

31 March 2021

Evidence-based recommendations on nerve transfer to partially restore upper limb function in people with tetraplegia. This involves connecting an undamaged, functioning, but non-essential nerve near the injury to the damaged essential nerve.

Result type

HealthTech guidance

Published

24 April 2018